TipRanks
Vivoryon Therapeutics AG (GB:0R3M)
LSE:0R3M
UK Market

Vivoryon Therapeutics AG (0R3M) Technical Analysis

2 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Vivoryon Therapeutics AG’s (0R3M) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Vivoryon Therapeutics AG is a Sell.
Vivoryon Therapeutics AG’s (0R3M) 20-Day exponential moving average is 1.11, while Vivoryon Therapeutics AG’s (0R3M) share price is €1.14, making it a Sell.
Vivoryon Therapeutics AG’s (0R3M) 50-Day exponential moving average is 1.13, while Vivoryon Therapeutics AG’s (0R3M) share price is €1.14, making it a Sell.

Vivoryon Therapeutics AG (0R3M) Pivot Points

Oct 01, 2026, 12:36 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.10
1.10
1.10
1.10
1.10
1.10
1.10
Fibonacci
1.10
1.10
1.10
1.10
1.10
1.10
1.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vivoryon Therapeutics AG (0R3M) Moving Averages

Oct 01, 2026, 12:36 PM
Period
Simple
Exponential
MA5
1.10Sell
1.10Sell
MA10
1.10Buy
1.10Sell
MA20
1.11Sell
1.11Sell
MA50
1.14Sell
1.13Sell
MA100
1.16Sell
1.18Sell
MA200
1.29Sell
1.30Sell
Vivoryon Therapeutics AG’s (0R3M) 10-Day exponential moving average is 1.10, while Vivoryon Therapeutics AG’s (0R3M) share price is €1.14, making it a Sell.
Vivoryon Therapeutics AG’s (0R3M) 100-Day exponential moving average is 1.18, while Vivoryon Therapeutics AG’s (0R3M) share price is €1.14, making it a Sell.
Vivoryon Therapeutics AG’s (0R3M) stock price is €1.14 and Vivoryon Therapeutics AG’s (0R3M) 50-day simple moving average is 1.14, creating a Sell signal.
Vivoryon Therapeutics AG’s (0R3M) stock price is €1.14 and Vivoryon Therapeutics AG’s (0R3M) 100-day simple moving average is 1.16, creating a Sell signal.
Vivoryon Therapeutics AG’s (0R3M) stock price is €1.14 and Vivoryon Therapeutics AG’s (0R3M) 200-day simple moving average is 1.29, creating a Sell signal.

Vivoryon Therapeutics AG (0R3M) Technical Indicators

Oct 01, 2026, 12:36 PM
Name
Value
Implied Action
RSI (14)
42.10
Neutral
STOCH (9,6)
42.86
Neutral
STOCHRSI (14)
33.33
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
12.96
Buy
Williams %R
-66.67
Buy
CCI (14)
-45.01
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
31.72
Neutral
ROC
-0.90
Sell
Vivoryon Therapeutics AG’s (0R3M) Relative Strength Index (RSI) is 42.10, creating a Neutral signal.
Vivoryon Therapeutics AG’s (0R3M) Trend Strength Indicator (ADX) is 12.96, creating a Buy signal.
Vivoryon Therapeutics AG’s (0R3M) Commodity Channel Index (CCI) is -45.01, creating a Neutral signal.
Vivoryon Therapeutics AG’s (0R3M) Price Rate of Change (ROC) is -0.90, creating a Sell signal.

FAQ

Is 0R3M a Buy, Hold, or Sell?
Based on 0R3M’s technical indicators, 0R3M is a Sell.
    What is 0R3M’s RSI (14)?
    0R3M’s RSI (14) is 42.10, which suggests 0R3M is a Neutral.
      What is 0R3M’s MACD?
      0R3M’s MACD is -0.01, which suggests 0R3M is a Sell.
        What is 0R3M’s 5-day moving average?
        0R3M’s 5-day moving average is 1.10, which suggests 0R3M is a Sell.
          What is 0R3M’s 20-day moving average?
          0R3M 20-day moving average is 1.11, which suggests 0R3M is a Sell.
            What is 0R3M’s 50-day moving average?
            0R3M’s 50-day moving average is 1.14, which suggests 0R3M is a Sell.
              What is 0R3M’s 200-day moving average?
              0R3M’s 200-day moving average is 1.29, which suggests 0R3M is a Sell.
                What is 0R3M’s Williams % R (14)?
                0R3M’s Williams % R (14) is -66.67, which suggests 0R3M is a Buy.
                  What is 0R3M’s CCI (14)?
                  0R3M’s CCI (14) is -45.01, which suggests 0R3M is a Neutral.
                    What is the share price of Vivoryon Therapeutics AG?